CorVel profit climbs 17% for fiscal year 2026 on health tech demand
CorVel (NASDAQ:CRDL) reported its financial results for the fourth quarter and fiscal year ended March 31, 2026, delivering top-line expansion and a double-digit increase in earnings per share as investments in artificial intelligence and automation optimized clinical workflows.


_1403676_640x360_2500734531803-640x360.webp&w=3840&q=75)

_1403671_640x360_2500734531800-640x360.webp&w=3840&q=75)

_1403651_640x360_2500735555690-640x360.webp&w=3840&q=75)




